Ver Publicación - Prisma - Unidad de Bibliometría

Identification of biomarkers for glycaemic deterioration in type 2 diabetes

Slieker, Roderick C.; Donnelly, Louise A.; Akalestou, Elina; Lopez-Noriega, Livia; Melhem, Rana; Güneş, Ayşim; Abou Azar, Frederic; Efanov, Alexander; Georgiadou, Eleni; Muniangi-Muhitu, Hermine; Sheikh, Mahsa; Giordano, Giuseppe N.; Åkerlund, Mikael; Ahlqvist, Emma; Ali, Ashfaq; Banasik, Karina; Brunak, Søren; Barovic, Marko; Bouland, Gerard A.; Burdet, Frédéric; Canouil, Mickaël; Dragan, Iulian; Elders, Petra J.M.; Fernandez, Celine; Festa, Andreas; Fitipaldi, Hugo; Froguel, Phillippe; Gudmundsdottir, Valborg; Gudnason, Vilmundur; Gerl, Mathias J.; van der Heijden, Amber A.; Jennings, Lori L.; Hansen, Michael K.; Kim, Min; Leclerc, Isabelle; Klose, Christian; Kuznetsov, Dmitry; Mansour Aly, Dina; Mehl, Florence; Marek, Diana; Melander, Olle; Niknejad, Anne; Ottosson, Filip; Pavo, Imre; Duffin, Kevin; Syed, Samreen K.; Shaw, Janice L.; Cabrera, Over; Pullen, Timothy J.; Simons, Kai; Solimena, Michele; Suvitaival, Tommi; Wretlind, Asger; Rossing, Peter; Lyssenko, Valeriya; Legido Quigley, Cristina; Groop, Leif; Thorens, Bernard; Franks, Paul W.; Lim, Gareth E.; Estall, Jennifer; Ibberson, Mark; Beulens, Joline W.J.; ’t Hart, Leen M. ; Pearson, Ewan R. ; Rutter, Guy A. 

Tipo: Artículo
Año de Publicación: 2023
Volumen: 14
Número: 1
Número de artículo: 2533
Acceso abierto: Vía dorada
Fuente Nº Citas Fecha Actualización
scopus1613-11-2024
wos1630-10-2024
Dimensions
PlumX
Altmetric

Año: 2023

Journal Impact Factor (JIF): 14.70

CategoríaEdiciónPosiciónCuartilTercilDecil
MULTIDISCIPLINARY SCIENCESSCIE8/134Q1T1D1

Año: 2023

Journal Citation Indicator (JCI): 3,280

CategoríaPosiciónCuartilTercilDecilPercentil
MULTIDISCIPLINARY SCIENCES8/135Q1T1D194,44

Año:

2023

CiteScore:

24,900

CategoríaPosiciónCuartilTercilDecil
Biochemistry, Genetics and Molecular Biology (all)7/221Q1T1D1
Chemistry (all)16/408Q1T1D1
Physics and Astronomy (all)7/243Q1T1D1

SJR año:

2023

Factor de Impacto:

4,887

CategoríaPosiciónCuartilTercilDecil
Biochemistry, Genetics and Molecular Biology (miscellaneous)11/304Q1T1D1
Chemistry (miscellaneous)14/495Q1T1D1
Physics and Astronomy (miscellaneous)9/304Q1T1D1
No existen datos para la revista de esta publicación.
Agencia Código de Proyecto
Canada Research Chair in Adipocyte Development115881
CIHR2009-1039
CIHR Project Grant-
Diabetes UK ProjectPJT-153144
EFPIA-
European Union-
Experimental Challenge Grant (DIVA)BDA16/0005485
Faculty of Medicine at Lund University-
Icelandic Research Fund113102006
Innovation Canada-
Innovative Medicines Initiative 2 Joint Undertaking-
MRCMR/J0003042/1; MR/L020149/1; MR/L02036X/1
Netherlands Organisation for Health Research and Development459001015; PJT-168853
Swedish Foundation for Strategic Research102820/Z/13/Z
Swedish governmental funding of clinical research (ALF)-
Swedish Research Council2020-02191; 2020-02191
Swiss State Secretariat for Education, Research and Innovation (SERI)184845-051
Vinnova Swelife16.0097
Wellcome Trust212625/Z/18/Z
Wellcome Trust Investigator AwardMR/R022259/1
Wellcome Trust New Investigator Award212625/Z/18/Z
Nota: los datos sobre financiación provienen de la WOS
# Autor Afiliación
1Slieker, Roderick C.Leiden University Medical Center - LUMC; Amsterdam Public Health (Netherlands)
2Donnelly, Louise A.University of Dundee School of Medicine (United Kingdom)
3Akalestou, ElinaImperial College London (United Kingdom)
4Lopez-Noriega, LiviaImperial College London (United Kingdom)
5Melhem, RanaCentre Hospitalier de L'Universite de Montreal (Canada)
6Güneş, AyşimUniversity of Montreal (Canada)
7Abou Azar, FredericCentre Hospitalier de L'Universite de Montreal (Canada)
8Efanov, AlexanderEli Lilly and Company (United States)
9Georgiadou, EleniImperial College London (United Kingdom)
10Muniangi-Muhitu, HermineImperial College London (United Kingdom)
11Sheikh, MahsaImperial College London (United Kingdom)
12Giordano, Giuseppe N.Institutionen för Kliniska Vetenskaper, Malmö (Sweden)
13Åkerlund, MikaelInstitutionen för Kliniska Vetenskaper, Malmö (Sweden)
14Ahlqvist, EmmaInstitutionen för Kliniska Vetenskaper, Malmö (Sweden)
15Ali, AshfaqSteno Diabetes Center Copenhagen (Denmark)
16Banasik, KarinaNovo Nordisk Foundation Center for Protein Research (Denmark)
17Brunak, SørenNovo Nordisk Foundation Center for Protein Research (Denmark)
18Barovic, MarkoUniversitätsklinikum Carl Gustav Carus Dresden (Germany)
19Bouland, Gerard A.Leiden University Medical Center - LUMC (Netherlands)
20Burdet, FrédéricSwiss Institute of Bioinformatics (Switzerland)
21Canouil, Mickaël(Epi)génomique Fonctionnelle et Physiologie Moléculaire Du Diabète et Maladies Associées (France)
22Dragan, IulianSwiss Institute of Bioinformatics (Switzerland)
23Elders, Petra J.M.Amsterdam Public Health (Netherlands)
24Fernandez, CelineInstitutionen för Kliniska Vetenskaper, Malmö (Sweden)
25Festa, AndreasEli Lilly Regional Operations GmbH; LK Stockerau (Austria)
26Fitipaldi, HugoInstitutionen för Kliniska Vetenskaper, Malmö (Sweden)
27Froguel, PhillippeImperial College London; (Epi)génomique Fonctionnelle et Physiologie Moléculaire Du Diabète et Maladies Associées (United Kingdom)
28Gudmundsdottir, ValborgIcelandic Heart Association; Læknadeild Háskóla Íslands (Iceland)
29Gudnason, VilmundurIcelandic Heart Association; Læknadeild Háskóla Íslands (Iceland)
30Gerl, Mathias J.Lipotype GmbH (Germany)
31van der Heijden, Amber A.Amsterdam Public Health (Netherlands)
32Jennings, Lori L.Novartis Institutes for BioMedical Research, Inc. (United States)
33Hansen, Michael K.Janssen Research & Development (Belgium)
34Kim, MinFaculty of Life Sciences & Medicine; Steno Diabetes Center Copenhagen (United Kingdom)
35Leclerc, IsabelleImperial College London; Centre Hospitalier de L'Universite de Montreal (United Kingdom)
36Klose, ChristianLipotype GmbH (Germany)
37Kuznetsov, DmitrySwiss Institute of Bioinformatics (Switzerland)
38Mansour Aly, DinaInstitutionen för Kliniska Vetenskaper, Malmö (Sweden)
39Mehl, FlorenceSwiss Institute of Bioinformatics (Switzerland)
40Marek, DianaSwiss Institute of Bioinformatics (Switzerland)
41Melander, OlleInstitutionen för Kliniska Vetenskaper, Malmö (Sweden)
42Niknejad, AnneSwiss Institute of Bioinformatics (Switzerland)
43Ottosson, FilipStatens Serum Institut; Institutionen för Kliniska Vetenskaper, Malmö (Sweden)
44Pavo, ImreEli Lilly Regional Operations GmbH (Austria)
45Duffin, KevinEli Lilly and Company (United States)
46Syed, Samreen K.Eli Lilly and Company (United States)
47Shaw, Janice L.Eli Lilly and Company (United States)
48Cabrera, OverEli Lilly and Company (United States)
49Pullen, Timothy J.Imperial College London; King's College London (United Kingdom)
50Simons, KaiLipotype GmbH (Germany)
51Solimena, MicheleUniversitätsklinikum Carl Gustav Carus Dresden (Germany)
52Suvitaival, TommiSteno Diabetes Center Copenhagen (Denmark)
53Wretlind, AsgerSteno Diabetes Center Copenhagen (Denmark)
54Rossing, PeterKøbenhavns Universitet; Steno Diabetes Center Copenhagen (Denmark)
55Lyssenko, ValeriyaUniversitetet i Bergen; Institutionen för Kliniska Vetenskaper, Malmö (Sweden)
56Legido Quigley, CristinaFaculty of Life Sciences & Medicine; Steno Diabetes Center Copenhagen (United Kingdom)
57Groop, LeifHelsingin Yliopisto; Institutionen för Kliniska Vetenskaper, Malmö (Sweden)
58Thorens, BernardUniversité de Lausanne (UNIL) (Switzerland)
59Franks, Paul W.Harvard T.H. Chan School of Public Health; Institutionen för Kliniska Vetenskaper, Malmö (United States)
60Lim, Gareth E.Centre Hospitalier de L'Universite de Montreal (Canada)
61Estall, JenniferUniversity of Montreal (Canada)
62Ibberson, MarkSwiss Institute of Bioinformatics (Switzerland)
63Beulens, Joline W.J.University Medical Center Utrecht; Amsterdam Public Health (Netherlands)
64’t Hart, Leen M. Leiden University Medical Center - LUMC; Amsterdam Public Health (Netherlands)
65Pearson, Ewan R. University of Dundee School of Medicine (United Kingdom)
66Rutter, Guy A. Imperial College London; Centre Hospitalier de L'Universite de Montreal; Lee Kong Chian School of Medicine (United Kingdom)